Comprehensive Analysis of the Global Clinical Trials IndustryThe global clinical trials sector is experiencing a significant ...

Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) ...

Researchers have completed a comprehensive natural history study of SCN8A-related disorders, which represent a spectrum of neurological symptoms. The study, using retrospective clinical information ...

The annual meeting of the American Academy of Neurology was held this year from April 5 to 9 in San Diego. Participants ...

Over the past 5 decades, diversity in gender, racial, and ethnic representation among neurology faculty in the United States has increased; however, these changes are less pronounced among senior ...

clinical, and internship phases) across various universities throughout Ecuador. The study objective was to investigate the relationship between neurophobia and the probability of specializing in ...

according to a study published online April 17 in Stroke. Jukka Putaala, M.D., from Helsinki University Hospital and the University of Helsinki, and colleagues enrolled patients aged 18 to 49 ...

In frontotemporal dementia research, inflammatory proteins should be considered among blood biomarker panels. Pending additional studies, clinical treatments and interventions targeting inflammatory ...

Hyperfine (HYPR) announced the enrollment of initial patients in the NEURO PMR study. The NEURO PMR study is the first multi-center, ...

Real-world study will assess ... imaging available to neurology practices of all sizes, ultimately reducing healthcare costs while improving patient access and clinical outcomes.

Focal onset seizures: data include brivaracetam long-term clinical outcomes in pediatric patients with primary generalized seizures* from an open-label Phase 3 follow-up study 9 and healthcare ...